FEMY - Femasys Inc Stock Price & Dividend Safety Sector: Healthcare | Exchange: NASDAQ Capital Market Current Price & Safety Score Price: 1.37 USD StockBonds Safety Grade: F Altman Z-Score (Bankruptcy Risk): -18.38 StockBond Score: -6.35 Company Description Femasys Inc a biomedical company established in 2004 and based in Suwanee Georgia primarily targets the womens healthcare market within the United States The firms innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec alongside FemaSeed which is an artificial insemination offering For diagnostic purposes Femasys provides FemCerv a biopsy device utilized for endocervical curettage and FemEMB a product candidate intended for endometrial sampling to assist in the detection of uterine cancer Additionally the company markets its FemVue salineair device across various international regions including the US Europe Canada and Japan Its infertilityrelated products are supplied to obstetriciangynecologists other allied healthcare professionals womens healthcare provider organizations and reproductive endocrinologists The company also offers a range of nonsurgical product technologies